Dello Russo, Cinzia
 Distribuzione geografica
Continente #
EU - Europa 3.338
NA - Nord America 2.576
AS - Asia 618
SA - Sud America 28
OC - Oceania 10
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.574
Nazione #
US - Stati Uniti d'America 2.550
PL - Polonia 1.105
DE - Germania 753
IT - Italia 493
SE - Svezia 339
CN - Cina 248
SG - Singapore 178
UA - Ucraina 174
GB - Regno Unito 108
IE - Irlanda 93
FR - Francia 91
FI - Finlandia 68
IN - India 61
ID - Indonesia 60
RU - Federazione Russa 35
NL - Olanda 23
BR - Brasile 18
CA - Canada 18
BE - Belgio 17
TR - Turchia 13
VN - Vietnam 12
ES - Italia 11
AU - Australia 10
JP - Giappone 9
CZ - Repubblica Ceca 8
HK - Hong Kong 8
MX - Messico 8
AT - Austria 7
CL - Cile 7
IR - Iran 7
CH - Svizzera 5
IL - Israele 4
KR - Corea 3
LT - Lituania 3
MY - Malesia 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
CI - Costa d'Avorio 2
GR - Grecia 2
MN - Mongolia 2
SA - Arabia Saudita 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AR - Argentina 1
BO - Bolivia 1
EG - Egitto 1
HU - Ungheria 1
NP - Nepal 1
PE - Perù 1
PK - Pakistan 1
QA - Qatar 1
TH - Thailandia 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 6.574
Città #
Warsaw 1.096
Chandler 393
Ashburn 228
Fairfield 190
Singapore 136
Jacksonville 135
Houston 132
Wilmington 118
Woodbridge 105
San Mateo 101
Verona 94
Dublin 93
Cambridge 82
Cattolica 82
Seattle 81
Ann Arbor 79
Nanjing 66
Milan 63
Jakarta 59
New York 53
Bremen 48
Munich 48
Dearborn 46
Rome 46
Lawrence 34
Nürnberg 34
Moscow 31
Redwood City 28
Beijing 27
Chicago 25
Helsinki 24
Nanchang 24
Boston 23
Marseille 23
Lancaster 21
Princeton 18
Brussels 17
Mountain View 17
Philadelphia 15
Redmond 15
Los Angeles 14
Dong Ket 12
Nuremberg 12
Phoenix 12
Pune 12
Shanghai 12
Boardman 11
Izmir 11
London 11
Fremont 10
Hangzhou 10
Jiaxing 10
Scottsdale 10
Falkenstein 9
Leawood 9
Naples 9
San Diego 9
Shenyang 9
Sydney 9
Toronto 9
University Park 9
Brasília 8
Hebei 8
Hong Kong 8
Kraków 8
Guangzhou 7
Lappeenranta 7
Manchester 7
Cagliari 6
Changsha 6
Kunming 6
Washington 6
Zhengzhou 6
Athens 5
Busto Arsizio 5
Cologne 5
Corchiano 5
Ferrara 5
Norwalk 5
Santiago 5
Simi Valley 5
Tianjin 5
Fondi 4
Jinan 4
Paris 4
Pisa 4
Priverno 4
Salvador 4
San Giovanni la Punta 4
Tampa 4
Vienna 4
Bologna 3
Brno 3
Council Bluffs 3
Delhi 3
Hamburg 3
Indiana 3
Lake Forest 3
Monmouth Junction 3
Mumbai 3
Totale 4.360
Nome #
The mTOR kinase inhibitors polarize glioma-activated microglia to express a M1 phenotype 361
Monocytes from depressed patients display an altered pattern of response to endotoxin challenge 351
mTOR kinase: a possible pharmacological target in the management of chronic pain 350
Novel sensitive, specific and rapid pharmacogenomic test for the prediction of abacavir hypersensitivity reaction: HLA-B*57:01 detection by real-time PCR 321
Proinflammatory-activated trigeminal satellite cells promote neuronal sensitization: relevance for migraine pathology 308
Expression of iNOS, CD163 and ARG-1 taken as M1 and M2 markers of microglial polarization in human glioblastoma and the surrounding normal parenchyma 308
The mTOR kinase inhibitor rapamycin decreases iNOS mRNA stability in astrocytes 304
The anti-inflammatory effects of dimethyl fumarate in astrocytes involve glutathione and haem oxygenase-1 279
The human microglial HMC3 cell line: where do we stand? A systematic literature review 224
Effects of remifentanil on human C20 microglial pro-inflammatory activation 164
Buprenorphine inhibits bradykinin-induced release of calcitonin gene-related peptide from rat trigeminal neurons via both μ-opioid and nociceptin/orphanin peptide receptors. 146
Antiretrovirals inhibit arginase in human microglia 130
Trigeminal satellite cells express functional calcitonin gene-related peptide receptors, whose activation enhances interleukin-1β pro-inflammatory effects. 127
Stress-related biomarkers of dream recall and implicit memory under anaesthesia 120
Trigeminal satellite cells express functional calcitonin gene-related peptide receptors, whose activation enhances interleukin-1β pro-inflammatory effects 110
Antiretrovirals inhibit arginase in human microglia 107
The activation of type 1 corticotropin releasing factor receptor (CRF-R1) inhibits proliferation and promotes differentiation of neuroblastoma cells in vitro via p27Kip1 protein up-regulation and c-Myc mRNA down-regulation 105
Modulatory effects of the CCR5 antagonist maraviroc on microglial pro-inflammatory activation elicited by gp120 102
Antinociceptive activity of buprenorphine and lumiracoxib in the rat orofacial formalin test: a combination analysis study. 101
Peripheral antinociceptive effects of low doses of naloxone in an in vivo and in vitro model of trigeminal nociception 99
Antiretroviral agents increase NO production in gp120/IFNγ-stimulated cultures of rat microglia via an arginase-dependent mechanism 95
Proinflammatory-activated glioma cells induce a switch in microglial polarization and activation status, from a predominant M2b phenotype to a mixture of M1 and M2a/B polarized cells 94
Detection of HLA-B*57:01 by real-time PCR: implementation into routine clinical practice and additional validation data 93
Rapamycin reduces clinical signs and neuropathic pain in a chronic model of experimental autoimmune encephalomyelitis 90
Trigeminal satellite cells modulate neuronal responses to triptans: relevance for migraine therapy. 89
Peripheral antinociceptive effects of low doses of naloxone in an in vivo and in vitro model of trigeminal nociception. 88
Endocrine disruptors and human corpus luteum: in vitro effects of phenols on luteal cells function. 85
The mTOR kinase inhibitor rapamycin enhances the expression and release of pro-inflammatory cytokine interleukin 6 modulating the activation of human microglial cells 85
Exploiting microglial functions for the treatment of glioblastoma 83
Involvement of mTOR kinase in cytokine-dependent microglial activation and cell proliferation 82
Trigeminal satellite cells modulate neuronal responses to triptans: relevance for migraine therapy. 79
Pro-inflammatory-activated glioma cells induce a switch in microglial polarization and activation status, from a predominant M2b phenotype to a mixture of M1 and M2a/b polarized cells 79
Endocrine disruptors and human reproductive failure: the in vitro effect of phthalates on human luteal cells 78
Dimethyl fumarate induced lymphopenia in multiple sclerosis: A review of the literature 77
Diverging effects of cortistatin and somatostatin on the production and release of prostanoids from rat cortical microglia and astrocytes 76
Comparative Analysis of Real-Time Polymerase Chain Reaction Methods to Typing HLA-B*57:01 in HIV-1-Positive Patients 76
A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study 75
mTOR kinase, a key player in the regulation of glial functions: Relevance for the therapy of multiple sclerosis 73
Endocrine disruptors and human corpus luteum: in vitro effects of phenols on luteal cells function 73
Diffusion of complementary evolving pharmaceutical innovations: The case of Abacavir and its pharmacogenetic companion diagnostic in Italy 73
A comparison between the assessments of progression-free survival by local investigators versus blinded independent central reviews in phase III oncology trials 73
The emerging role of the BDNF-TrkB signaling pathway in the modulation of pain perception 72
Exploiting Microglial Functions for the Treatment of Glioblastoma 70
Local Investigators Significantly Overestimate Overall Response Rates Compared to Blinded Independent Central Reviews in Phase 2 Oncology Trials 64
Optimizing Patient Selection to Maximize Drug Efficacy: the Expanding Role of Pharmacogenomics in the Clinical Development of Pembrolizumab for the Treatment of Non-small Cell Lung Cancer 63
The novel HSP90 inhibitor, PU-H71, suppresses glial cell activation but weakly affects clinical signs of EAE 62
Relationship between blood remifentanil concentration and stress hormone levels during pneumoperitoneum in patients undergoing laparoscopic cholecystectomy 60
First external quality assurance program of the Italian HLA-B*57:01 Network assessing the performance of clinical virology laboratories in HLA-B*57:01 testing 59
Physiological adaptations affecting drug pharmacokinetics in space: what do we really know? A critical review of the literature 58
The Future of Personalized Medicine in Space: From Observations to Countermeasures 48
Noradrenaline in Alzheimer's Disease: A New Potential Therapeutic Target 47
LAT1, a novel pharmacological target for the treatment of glioblastoma 44
REMIFENTANIL DOES NOT AFFECT HUMAN MICROGLIAL IMMUNE ACTIVATION IN RESPONSE TO PRO-INFLAMMATORY CYTOKINES 42
Genome-wide analyses of platinum-induced ototoxicity in childhood cancer patients: Results of GO-CAT and United Kingdom MAGIC consortia 40
Local Investigators Significantly Overestimate Overall Response Rates Compared to Blinded Independent Central Reviews in Uncontrolled Oncology Trials: A Comprehensive Review of the Literature 39
Remifentanil-induced hyperalgesia in healthy volunteers: a systematic review and meta-analysis of randomized controlled trials 36
What is the weight of expectation bias in oncology trials? 31
Perioperative analgesia in the elderly 22
Totale 6.690
Categoria #
all - tutte 24.023
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.023


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020382 0 0 0 0 0 0 0 51 110 41 113 67
2020/2021730 36 74 20 68 93 44 119 8 98 57 95 18
2021/2022678 63 51 4 46 55 17 24 79 21 44 170 104
2022/20231.164 138 139 75 166 107 118 40 116 164 30 43 28
2023/2024750 42 149 33 86 40 101 72 21 9 38 73 86
2024/2025462 29 37 95 45 104 81 37 34 0 0 0 0
Totale 6.690